
In this video, Antonio Palumbo, MD, discusses results of the CASTOR trial, which studied daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma.

Your AI-Trained Oncology Knowledge Connection!


Published: June 6th 2016 | Updated: